BIOLASE, Inc. provided earnings guidance for the Full-Year 2023. For the period, the company's full-year 2023 revenue is expected to be in the range of $48.9 million to $49.2 million, achieving 1% growth over 2022 despite the industry headwinds and interest rate environment.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.148 USD | 0.00% | +6.47% | -86.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.81% | 4.92M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- BIOL Stock
- News BIOLASE, Inc.
- BIOLASE, Inc. Provides Earnings Guidance for the Full-Year 2023